Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Nanobiotix achieves milestone in cancer treatment with NBTXR3, secures $20m from Janssen NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX), a leader in the field of biotechnology, announced a significant achievement in… byPallavi MadhirajuJanuary 30, 2024